N6-methyladenosine (m6A) is the most pervasive RNA modification in eukaryotic cells. The
dynamic and reversible m6A modification of RNA plays a critical role in the occurrence and …

Colorectal cancer (CRC) is one of the most prevalent cancers and one of the leading causes
of cancer death. Recent studies have provided evidence that N 6-methyladenosine (m 6 A) …

Colorectal cancer is the third most common malignant tumor worldwide, causing serious
harm to human health. Epigenetic modification, especially RNA methylation modification …

As the predominant modification in RNA, N 6-methyladenosine (m 6 A) has attracted
increasing attention in the past few years since it plays vital roles in many biological …

Colorectal cancers (CRC), which includes colon cancer (CC) and rectal cancer (RC), are
some of the most common malignant tumors that are prone to distant metastasis. Its high …

Gastrointestinal (GI) cancer is a series of malignant tumors with a high incidence globally.
Although approaches for tumor diagnosis and therapy have advanced substantially, the …

Aim: To comprehensively profile the landscape of the mRNA N6-methyladenosine (m6A)
modification in human colorectal cancer (CRC). Methods: Methylated RNA …

N6-methyladenosine (m6A) is the most common epigenetic modification of eukaryotic RNA,
which can participate in the growth and development of the body and a variety of …

N6-Methyladenosine (m6A) methylation is one of the most extremely examined RNA
modifications. M6A modification evidently impacts cancer development by effecting RNA …

Abstract N6-methyladenosine (m6A), the most abundant internal modification of RNA in
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …